Understand the source comparison
Peptides for Chest Wrinkles: Clinical Protocol Comparison
GHK-Cu (Copper Peptide) Chelates copper ions to activate lysyl oxidase, cross-linking procollagen into mature collagen fibers 1–3% in serum or cream base Twice daily (morning + night) 8–12 weeks High. Multiple RCTs show 12–20% increase in dermal density Palmit
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- GHK-Cu (Copper Peptide)
- Chelates copper ions to activate lysyl oxidase, cross-linking procollagen into mature collagen fibers
- 1–3% in serum or cream base
- Twice daily (morning + night)
- 8–12 weeks
- High. Multiple RCTs show 12–20% increase in dermal density
- Palmitoyl Pentapeptide-4 (Matrixyl)
- Mimics damaged collagen fragments, signals fibroblasts via TGF-beta receptors to upregulate procollagen I synthesis
- 3–5% in phospholipid carrier
- Twice daily
- 10–14 weeks
- Very high. Landmark IJCS study demonstrated 117% collagen increase
- Palmitoyl Tripeptide-38 (Matrixyl synthe'6)
- Stimulates collagen VI and laminin-5, strengthening dermal-epidermal junction
- 2–4%
- Once daily (evening)
- 6–10 weeks
- Moderate. Single published trial shows 31% DEJ improvement
- Acetyl Hexapeptide-8 (Argireline)
- SNARE complex inhibitor. Reduces muscle contraction depth
- 5–10%
- 4–8 weeks
- Low for chest wrinkles. Mechanism targets expression lines, not photodamage